Home Cart Sign in  
Chemical Structure| 2222941-37-7 Chemical Structure| 2222941-37-7

Structure of Inobrodib
CAS No.: 2222941-37-7

Chemical Structure| 2222941-37-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Inobrodib is a potent and selective p300/CBP bromodomain inhibitor.

Synonyms: CCS1477; CBP-IN-1; Inobrodibum

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Inobrodib

CAS No. :2222941-37-7
Formula : C30H32F2N4O3
M.W : 534.60
SMILES Code : O=C1N(C2=CC=C(F)C(F)=C2)[C@H](C3=NC4=CC(C5=C(C)ON=C5C)=CC=C4N3[C@H]6CC[C@H](OC)CC6)CCC1
Synonyms :
CCS1477; CBP-IN-1; Inobrodibum
MDL No. :MFCD32062689
InChI Key :SKDNDJWEBPQKCS-RIQBOWGZSA-N
Pubchem ID :134457551

Safety of Inobrodib

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P362-P403+P233-P501

Related Pathways of Inobrodib

epigenetics

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Primary hepatic stellate cells 1 μM 4 days Validate the inhibitory effect of Inobrodib on collagen in primary hepatic stellate cells PMC11466758
LX-2 cells 1 μM 7 days Validate the inhibitory effect of Inobrodib on collagen in hepatic stellate cell line LX-2 PMC11466758

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
B-NDG mice GEM-resistant PDX model Oral 30 mg/kg Every other day for 21 days Evaluate the in vivo effect of Inobrodib combined with GEM on GEM-resistant PDAC, showing that the combination treatment significantly inhibits tumor growth PMC11653652

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.87mL

0.37mL

0.19mL

9.35mL

1.87mL

0.94mL

18.71mL

3.74mL

1.87mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
 

Historical Records

Categories